No statistically significant difference between the 2 fluids in mortality Albumin demonstrated a safety profile comparable with crystalloidsHES was associated with a higher risk of acute kidney injury and increased need for renal replacement therapyCrystalloids remain the first-line choice for fluid resuscitation due to their lower cost and favorable safety profile. This evidence concerns the gene ALB and acute kidney injury.